DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
n••••••
Healthcare & Pharmaceuticalsgroup grade Bon a schedule nowsponsor unattributed
Principal held
at least $2.6M
sum of BDC pieces, a lower bound
Fair value
$851,305
32c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
0 equity pieces beside them
Next maturity
Dec 15, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
9
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| second lien term loan second lien | at least $2.1M | 28c | SOFR+675 bp | Dec 17, 2029 | 1 |
| first lien term loan first lien | at least $524,079 | 51c | SOFR+525 bp | Dec 15, 2028 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment Type 1st Lien Term Loan Index S+ Spread 5.25% Interest Rate 8.98% Acquisition D | $115,920 | $59,119 52c | SOFR+525 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment Type 1st Lien Term Loan Index S+ Spread 4.00% Interest Rate 7.73% Acquisition D | $408,159 | $208,569 51c | SOFR+400 bp |
| A•••• C••••• B•• I••• | term loan second lien Investment Type 2nd Lien Term Loan Index S+ Spread 6.75% Interest Rate 10.48% Acquisition | $490,000 | $135,975 28c | SOFR+675 bp |
| A•••• C••••• B•• I••• | term loan second lien Investment Type 2nd Lien Term Loan Index S+ Spread 4.00% Interest Rate 7.73% Acquisition D | $1.6M | $447,642 28c | SOFR+400 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $2.6M | $851,305 | 32c | 0 |
| Mar 31, 2026 | 1 | $2.6M | $1.3M | 51c | 0 |
| Dec 31, 2025 | 1 | $2.6M | $1.9M | 74c | 0 |
| Sep 30, 2025 | 1 | $2.6M | $2.3M | 89c | 0 |
| Jun 30, 2025 | 1 | $2.6M | $2.6M | 100c | 0 |
| Mar 31, 2025 | 1 | $2.6M | $2.6M | 100c | 0 |
| Dec 31, 2024 | 1 | $5.3M | $5.2M | 99c | 0 |
| Sep 30, 2024 | 1 | $3.0M | $2.1M | 70c | 0 |
| Jun 30, 2024 | 1 | $3.0M | $2.2M | 74c | 0 |
| Mar 31, 2024 | 1 | $3.0M | $2.1M | 71c | 0 |
| Dec 31, 2023 | 1 | $6.0M | $5.5M | 93c | 0 |
| Sep 30, 2023 | 1 | $3.0M | $2.8M | 94c | 0 |
| Jun 30, 2023 | 1 | $3.0M | $2.8M | 95c | 0 |
| Dec 31, 2022 | 1 | $3.0M | $3.0M | 100c | 0 |
What changed
- Spread changed (observed)Jun 30, 2026
- Maturity shortened (observed)Jun 30, 2026
- Marked down across lendersMar 31, 2026
- Marked down (one lender)Mar 31, 2026
- Marked down across lendersDec 31, 2025
- Marked down (one lender)Dec 31, 2025
- Marked down across lendersSep 30, 2025
- Marked down (one lender)Sep 30, 2025
- Maturity extended (observed)Dec 31, 2024
- Mark recoveredDec 31, 2024
- Spread increasedDec 31, 2024
- Maturity extended (observed)Dec 31, 2024
- Mark recoveredJun 30, 2024
- Marked down across lendersMar 31, 2024
- Marked down (one lender)Mar 31, 2024
- Marked down across lendersJun 30, 2023
- Marked down (one lender)Jun 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- NTHRIVEderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it